Hostname: page-component-7b7567c8c-2jgqx Total loading time: 0 Render date: 2026-11-19T19:42:30.828Z Has data issue: false hasContentIssue false

STAT signalling in the heart and cardioprotection

Published online by Cambridge University Press:  12 July 2006

Surinder M. Soond
Affiliation:
Institute of Child Health, University College London, London, WC1N 1EH, UK.
David S. Latchman
Affiliation:
Institute of Child Health, University College London, London, WC1N 1EH, UK.
Anastasis Stephanou
Affiliation:
Institute of Child Health, University College London, London, WC1N 1EH, UK.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

During the past six years, great progress has been made in defining the key cellular and molecular signalling pathways that determine the fate of cardiac myocytes after ischaemia–reperfusion (IR) and consequently the severity of myocardial infarction. Among the complex network of kinases and transcription factors that mediate signals during IR is the STAT family of ‘signal transducers and activators of transcription’. During IR they are inducibly activated by Janus kinases and have the capability of transcriptionally regulating pro-survival and apoptotic gene expression. In this review we focus on recent progress made in elucidating the regulation and role of the STAT family of proteins during cardioprotective signalling events in myocardial preconditioning and during IR injury in cardiac myocyte cells and the myocardium. Moreover, we also highlight developments in understanding how this signalling pathway might be amenable to therapeutic intervention, permitting cardiac myocyte survival following IR.

Information

Type
Review Article
Copyright
© 2006 Cambridge University Press